Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Assets | $ 15.56B | $ 14.84B | $ 12.32B | $ 10.84B | $ 9.91B |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | $ 14.24B | $ 12.75B | $ 11.17B | $ 9.16B | $ 8.74B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | $ -10.00M | $ 994.00M | $ 42.00M | $ -622.00M | $ -428.00M |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |